CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,014 | +4.4% | 600 | +20.0% | 0.00% | – |
| Q2 2023 | $6,720 | +102.7% | 500 | +150.0% | 0.00% | – |
| Q1 2023 | $3,316 | +122.8% | 200 | +150.0% | 0.00% | – |
| Q4 2022 | $1,488 | +48.8% | 80 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -100.0% | 80 | -98.5% | 0.00% | – |
| Q1 2021 | $23,972,000 | +266255.6% | 5,200 | +108.0% | 0.00% | – |
| Q4 2019 | $9,000 | -60.9% | 2,500 | -44.4% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | +155.6% | 4,500 | +80.0% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |